395 related articles for article (PubMed ID: 19132177)
1. [Haemostatic aspects in clinical oncology].
Langer F; Holstein K; Eifrig B; Bokemeyer C
Hamostaseologie; 2008 Dec; 28(5):472-80. PubMed ID: 19132177
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
Rak J; Klement P; Yu J
Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
[TBL] [Abstract][Full Text] [Related]
3. [Haemostatic aspects in clinical oncology].
Langer F
Hamostaseologie; 2015; 35(2):152-64; quiz 165. PubMed ID: 25943078
[TBL] [Abstract][Full Text] [Related]
4. Haemostasis and cancer.
Francis JL
Med Lab Sci; 1989 Oct; 46(4):331-46. PubMed ID: 2693872
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin in thrombosis and cancer.
Mousa SA
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.
Langer F; Bokemeyer C
Hamostaseologie; 2012; 32(2):95-104. PubMed ID: 21792469
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor and cancer.
Milsom C; Rak J
Pathophysiol Haemost Thromb; 2008; 36(3-4):160-76. PubMed ID: 19176989
[TBL] [Abstract][Full Text] [Related]
8. Cancer, thrombosis and heparin-induced thrombocytopenia.
Prandoni P; Falanga A; Piccioli A
Thromb Res; 2007; 120 Suppl 2():S137-40. PubMed ID: 18023709
[TBL] [Abstract][Full Text] [Related]
9. Cancer and thrombosis in women - molecular mechanisms.
Rickles FR
Thromb Res; 2009; 123 Suppl 2():S16-20. PubMed ID: 19217469
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor and fibrin in tumor angiogenesis.
Fernandez PM; Patierno SR; Rickles FR
Semin Thromb Hemost; 2004 Feb; 30(1):31-44. PubMed ID: 15034796
[TBL] [Abstract][Full Text] [Related]
11. Procoagulant mechanisms in tumour cells.
Falanga A; Panova-Noeva M; Russo L
Best Pract Res Clin Haematol; 2009 Mar; 22(1):49-60. PubMed ID: 19285272
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
Mousa SA; Petersen LJ
Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
[TBL] [Abstract][Full Text] [Related]
13. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
Falanga A; Marchetti M; Vignoli A; Balducci D
Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis and malignancy: pathogenesis and prevention.
Schwartz JD; Simantov R
In Vivo; 1998; 12(6):619-24. PubMed ID: 9891224
[TBL] [Abstract][Full Text] [Related]
15. Does antithrombotic therapy improve survival in cancer patients?
Cunningham MS; Preston RJ; O'Donnell JS
Blood Rev; 2009 May; 23(3):129-35. PubMed ID: 19046797
[TBL] [Abstract][Full Text] [Related]
16. Cancer and thromboembolism: from biology to clinics.
Castelli R; Porro F
Minerva Med; 2006 Apr; 97(2):175-89. PubMed ID: 16760856
[TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation changes and neoplastic pathology].
Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotics in thrombosis and cancer.
Mousa SA
Hamostaseologie; 2005 Nov; 25(4):380-6. PubMed ID: 16395488
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Semin Thromb Hemost; 2002 Feb; 28(1):45-52. PubMed ID: 11885025
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
